Praxis Precision Medicines (PRAX) Assets Average (2022 - 2025)
Praxis Precision Medicines has reported Assets Average over the past 4 years, most recently at $667.1 million for Q4 2025.
- Quarterly results put Assets Average at $667.1 million for Q4 2025, up 48.36% from a year ago — trailing twelve months through Dec 2025 was $667.1 million (up 48.36% YoY), and the annual figure for FY2025 was $710.5 million, up 148.84%.
- Assets Average for Q4 2025 was $667.1 million at Praxis Precision Medicines, up from $424.6 million in the prior quarter.
- Over the last five years, Assets Average for PRAX hit a ceiling of $667.1 million in Q4 2025 and a floor of $97.3 million in Q4 2023.
- Median Assets Average over the past 4 years was $210.0 million (2022), compared with a mean of $291.1 million.
- Biggest five-year swings in Assets Average: plummeted 44.78% in 2023 and later soared 361.99% in 2024.
- Praxis Precision Medicines' Assets Average stood at $126.0 million in 2022, then fell by 22.76% to $97.3 million in 2023, then soared by 361.99% to $449.7 million in 2024, then skyrocketed by 48.36% to $667.1 million in 2025.
- The last three reported values for Assets Average were $667.1 million (Q4 2025), $424.6 million (Q3 2025), and $465.8 million (Q2 2025) per Business Quant data.